SIMVASTATIN
Generic: SIMVASTATIN
SIMVASTATIN is FDA application ANDA077691, sponsored by AUROBINDO PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Labeling; Incorrect or Missing Lot and/or Exp Date; some bottles labeled with lot number 05318054B i
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Failed Excipient Specifications and Presence of Foreign Tablets/Capsules; product manufactured using
CGMP Deviations: recalling drug products following an FDA inspection.
Failed Excipient Specifications; product manufactured using an excipient found to be OOS for conduct
Failed Excipient Specifications; product manufactured using an excipient found to be OOS for conduct
CGMP Deviations: recalling drug products following an FDA inspection.
CGMP Deviations: recalling drug products following an FDA inspection.
CGMP Deviations: recalling drug products following an FDA inspection.
CGMP Deviations: recalling drug products following an FDA inspection.